Evaluation of post operative pain in patients undergoing Percutaneous Nephrolithotomy Surgery

Evaluation of landmark guided erector spinae plane block versus local anaesthetic infiltration of the surgical site for post operative analgesia in patients undergoing Percutaneous Nephrolithotomy surgery: A comparative study - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/08/073029

Enrollment

Registered

2024-08-28

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N200- Calculus of kidney

Interventions

Intervention1: Inj Ropivacaine 0.75%: Inj Ropivacaine 0.75% Isobaric 20ml, one time, given as Erector spinae plane block, duration intervention 30min. Intervention2: Inj Ropivacaine 0.75%: Inj Ropivac

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient with ASA physical status 1 and 2 of either gender. 2. Age 18-65 years. 3. Patients posted for unilateral percutaneous nephrolithotomy surgery under general anesthesia, with endotracheal intubation.

Exclusion criteria

Exclusion criteria: 1) Known allergies to the drugs used. 2) Patients using analgesic drugs before surgery or posted for emergency or urgent surgery. 3) Patients with cognitive impairment or mental retardation. 4) Pregnant females. 5) Patients with history of alcohol or drug addiction. 6) Coagulopathy

Design outcomes

Primary

Measure	Time frame
To compare the time at which the first rescue analgesic dose of Inj. Tramadol 50 mg IV is required by patients with postoperative visual analogue scale (VAS) pain scores of = 4 in the ESPB and LAI groups.Timepoint: 24 hours	—

Secondary

Measure	Time frame
To study the incidence of post-operative nausea and vomiting (PONV) in ESPB & LAI groups within the first 24 hours after surgeryTimepoint: 24 hours	—

Countries

India

Contacts

Public ContactDr V S Kapurkar

Krishna institute of Medical Sciences

vskapurkar@gmail.com9881560540

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026